Cargando…

Immunosuppressants/azithromycin: Prolonged COVID-19 infection, off label use and lack of efficacy: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390989/ http://dx.doi.org/10.1007/s40278-021-01372-6

Ejemplares similares

Azithromycin: Lack of efficacy and off-label use: case report
Publicado: (2021)

Azithromycin/favipiravir/hydroxychloroquine: Lack of efficacy and off-label use: case report
Publicado: (2021)

Azithromycin/inosine-pranobex off label use: Lack of efficacy: case report
Publicado: (2022)

Azithromycin/eculizumab/hydroxychloroquine: Normocytic anaemia, lack of efficacy and off-label use: case report
Publicado: (2022)

Azithromycin/dexamethasone/voriconazole: Pulmonary aspergillosis following off-label use, and lack of efficacy: case report
Publicado: (2021)

Azithromycin/ceftriaxone/remdesivir: Bradycardia and lack of efficacy following off-label use: 2 case reports
Publicado: (2022)

Azithromycin/hydroxychloroquine/tocilizumab: QTc prolongation and off label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc prolongation and off label use: 3 case reports.
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc prolongation during off-label treatment: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: QT prolongation following off label use: case report
Publicado: (2022)

Azithromycin/hydroxychloroquine: Prolonged QTc during off label use: case report
Publicado: (2021)

Corticosteroids/immunosuppressants/steroids: COVID-19 and lack of efficacy following off label use: 7 case reports
Publicado: (2022)

Azithromycin/hydroxychloroquine: Prolonged QT interval during off label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Prolonged corrected QT following off label use: case report.
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc prolongation following off-label use: 2 case reports
Publicado: (2021)

Multiple drugs: Off-label use, lack of efficacy and acquired immunosuppression syndrome: case report
Publicado: (2022)

Multiple drugs: Severe COVID-19, prolonged viral shedding, lack of efficacy and off-label use: case report
Publicado: (2022)

Multiple drugs: QTc prolongation, lack of efficacy and off-label use: 3 case reports
Publicado: (2021)

Azithromycin/hydroxychloroquine interaction: QT interval prolongation following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Corrected QT-interval prolongation following off label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QT prolongation and ventricular extrasystole secondary to off label use: case report
Publicado: (2021)

Ceftriaxone/doxycycline/immunosuppressants: Disseminated histoplasmosis following an off label use and lack of efficacy: case report
Publicado: (2022)

Multiple drugs: COVID-19 infection, lack of efficacy and off-label use: case report
Publicado: (2021)

Azithromycin/enoxaparin sodium/hydroxychloroquine: Gastrointestinal bleeding, ischaemic stroke due to off-label use, and lack of efficacy: case report
Publicado: (2021)

Antivirals/immunosuppressants: COVID-19 infection and off label use: case report
Publicado: (2020)

Abatacept/immunosuppressants/ruxolitinib: Various toxicities following off-label use and lack of efficacy: 20 case reports
Publicado: (2022)

Multiple drugs: Recurrence of COVID-19 infection, off-label use and lack of efficacy: case report
Publicado: (2022)

Azithromycin/dexamethasone/prednisone: Lack of efficacy, off label use and rebound effect in the form of worsening of subacute thyroiditis: 3 case reports
Publicado: (2022)

Dexamethasone/meropenem: Infections, off label use and lack of efficacy: case report
Publicado: (2022)

Azithromycin/hydroxychloroquine: QT prolongation with a notched broad T-wave following off-label therapy: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QTc interval prolongation and torsades de pointes following off-label use: case report
Publicado: (2020)

Favipiravir: Lack of efficacy secondary to off label use in COVID-19: Case report: case report
Publicado: (2021)

Tocilizumab: Off label use and lack of efficacy: case report
Publicado: (2021)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)

Azithromycin/hydroxychloroquine: Lack of efficacy: 2 case reports
Publicado: (2022)

Immunosuppressants and antiviral: COVID-19 and lack of efficacy: case report
Publicado: (2022)

Multiple drugs: Lack of efficacy in COVID-19 pneumonia and off label use: case report
Publicado: (2021)

Multiple drugs: COVID-19 pneumonia, off-label use and lack of efficacy: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hb9ah8k78bpuhfg70g7pc4cjfi